PROMOMED Group expands bond program to 5 billion rubles

The Moscow Stock Exchange has registered changes to the PROMOMED DM LLC exchange-traded bond program. The volume of the 001P series bond program has been increased to 5 billion rubles. The nominal value of one bond is 1,000 rubles. The placement price is 100% of the face value. The circulation period is 3 years. The coupon period is 182 days. The new version of the program includes the possibility of placing separate issues of "green", social and/or infrastructure bonds.

The company invests the funds received from the bond placement in the development and production of active pharmaceutical substances and ready-made dosage forms, as well as the construction of new research laboratories and workshops. In the near future, PROMOMED plans to focus on expanding its portfolio by creating innovative antiviral, antibacterial, endocrinological and oncological drugs.
The successful placement of the debut issue of PROMOMED DM LLC's 001P-01 exchange-traded bonds on the Moscow Stock Exchange took place on December 24, 2020, at which time the company raised 1 billion rubles at a rate of 9.5% per annum. In June 2021, PROMOMED DM LLC paid the first coupon income on exchange-traded bonds on time and in full, with payments amounting to 47.37 million rubles. PROMOMED DM LLC's 001P-01 exchange-traded bonds are included in the listing of the Innovation and Investment Market sector of the Moscow Stock Exchange, which makes them more attractive to a wide range of investors, exempting them from personal income tax.